NCT03477591View on ClinicalTrials.gov

Evaluating the Impact of Evidence-based Information About PSA Testing on Prostate Cancer Screening Decisions

NACompletedINTERVENTIONAL
Enrollment

308

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

August 30, 2019

Study Completion Date

July 1, 2021

Conditions
Prostate Cancer
Interventions
OTHER

Evidence-based information

Evidence-based information on PSA testing such as blog posts, plain language evidence summaries and web resource ratings (quality-appraised online resources).

OTHER

Patient Decision Aid

Patient Decision Aid for prostate cancer screening decision

OTHER

Sham information

Educational information not specific to PSA testing or cancer screening

Trial Locations (1)

L8P0A1

McMaster University, Hamilton

All Listed Sponsors
collaborator

Canadian Cancer Society (CCS)

OTHER

lead

McMaster University

OTHER

NCT03477591 - Evaluating the Impact of Evidence-based Information About PSA Testing on Prostate Cancer Screening Decisions | Biotech Hunter | Biotech Hunter